文献速递骨软组织肉瘤与黑色素瘤

肉瘤患者经参考中心网络管理后全国生存率改善

Improved nationwide survival of sarcoma patients with a network of reference centers.
PubMed 文献 · Ann Oncol · 2024-01-20

研究评估法国自2010年起实施的肉瘤参考中心网络(NETSARC)对肉瘤患者诊疗与生存的影响,对比2010-2012年、2013-2015年、2016-2020年三个时期。结果显示2016-2020年总生存优于2013-2015年、更优于2010-2012年(P<0.0001),同时活检率、NETSARC多学科肿瘤委员会(MDTB)术前讨论率及R0切除率均提高,R2切除率下降。

要点

  • 2016-2020年肉瘤患者总生存优于2013-2015年和2010-2012年(P<0.0001)
  • 术前活检比例由62.9%升至72.6%,首次手术前NETSARC MDTB讨论比例由31.7%升至44.4%(P<0.0001)
  • 首次手术R0切除率由36.1%升至46.6%,R2切除率由10.9%降至7.9%

核心结论

  • 肉瘤国家参考网络的实施与肉瘤患者总生存改善及全国指南依从性提高相关。
  • 作者认为应鼓励将肉瘤患者转诊至专家网络,尽管指南依从性仍可进一步提高。

研究设计与样本

  • NETSARC为自2010年起由法国国家癌症研究所(INCa)资助、由26个肉瘤参考中心组成的网络,设有专门的多学科肿瘤委员会(MDTB)。
  • 患者特征、治疗与结局录入全国数据库,本次分析比较2010-2012年(非 exhaustive)、2013-2015年、2016-2020年三个时期的生存。
  • 自2010年起NETSARC+数据库共纳入43975例肉瘤、胃肠间质瘤(GIST)或中间恶性 connective tissue肿瘤患者(2013年前n=9266,2013-2015年n=12274,2016-2020年n=22435)。
  • 中位年龄56岁,50.5%为女性,13.2%诊断时已有转移。

主要发现

  • 2016-2020年总生存优于2013-2015年、更优于2010-2012年,在全人群、>18岁患者及转移与非转移患者中,单因素与多因素分析均显示(P<0.0001)。
  • 三个时期全国指南(CPGs)依从性显著改善:术前活检比例由62.9%升至72.6%。
  • 首次手术前经NETSARC MDTB讨论的患者比例由31.7%升至44.4%(P<0.0001)。
  • 首次手术R0切除比例由36.1%升至46.6%,R2切除比例由10.9%降至7.9%,NETSARC中心依从性与改善更佳。

关键数值与推荐

  • NETSARC由26个肉瘤参考中心组成,自2010年起获INCa资助。
  • 2010-2012年(非 exhaustive)、2013-2015年、2016-2020年三个时期总生存比较P<0.0001。
  • 术前活检比例62.9%升至72.6%;首次手术前NETSARC MDTB讨论比例31.7%升至44.4%(P<0.0001)。
  • R0切除比例36.1%升至46.6%;R2切除比例10.9%降至7.9%。

临床怎么用

  • 作者认为应鼓励将肉瘤患者转诊至专家网络,并指出指南依从性仍可进一步提高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We investigated the impact of the implementation of a network of reference centers for sarcomas (NETSARC) on the care and survival of sarcoma patients in France since 2010. PATIENTS AND METHODS: NETSARC (netsarc.org) is a network of 26 reference sarcoma centers with specialized multidisciplinary tumor boards (MDTBs), funded by the French National Cancer Institute (INCa) since 2010. Its aims are to improve the quality of diagnosis and care of sarcoma patients. Patients' characteristics, treatments, and outcomes are collected in a nationwide database. The objective of this analysis was to compare the survival of patients in three periods: 2010-2012 (non-exhaustive), 2013-2015, and 2016-2020. RESULTS: A total of 43 975 patients with sarcomas, gastrointestinal stromal tumors (GISTs), or connective tissue tumors of intermediate malignancy were included in the NETSARC+ database since 2010 (n = 9266 before 2013, n = 12 274 between 2013 and 2015, n = 22 435 in 2016-2020). Median age was 56 years, 50.5% were women, and 13.2% had metastasis at diagnosis. Overall survival was significantly superior in the period 2016-2020 versus 2013-2015 versus 2010-2012 for the entire population, for patients >18 years of age, and for both metastatic and non-metastatic patients in univariate and multivariate analyses (P < 0.0001). Over the three periods, we observed a significantly improved compliance to clinical practice guidelines (CPGs) nationwide: the proportion of patients biopsied before surgery increased from 62.9% to 72.6%; the percentage of patients presented to NETSARC MDTBs before first surgery increased from 31.7% to 44.4% (P < 0.0001). The proportion of patients with R0 resection on first surgery increased (from 36.1% to 46.6%), while R2 resection rate decreased (from 10.9% to 7.9%), with a better compliance and improvement in NETSARC centers. CONCLUSIONS: The implementation of the national reference network for sarcoma was associated with an improvement of overall survival and compliance to guidelines nationwide in sarcoma patients. Referral to expert networks for sarcoma patients should be encouraged, though a better compliance to CPGs can still be achieved.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Blay JY, Penel N, Valentin T, et al. Improved nationwide survival of sarcoma patients with a network of reference centers. Ann Oncol. 2024. PMID: 38246351. doi:10.1016/j.annonc.2024.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。